[1] MORGAN E, ARNOLD M, GINI A, et al.Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN[J]. Gut, 2023, 72(2): 338-344. [2] YANG Y, HAN Z, LI X, et al.Epidemiology and risk factors of colorectal cancer in China[J]. Chinese journal of cancer research[J]. Chin J Cancer Res, 2020, 32(6): 729-741. [3] 国家卫生健康委员会医政司,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2023版)[J/CD].消化肿瘤杂志(电子版), 2023,15(3): 177-206. [4] WANG L, WANG H, JIN K, et al.Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases[J]. BMC Surg, 2020, 20(1): 16. [5] JIA C, LIU G, WANG X, et al.Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study[J]. Jpn J Radiol, 2021, 39(11): 1059-1068. [6] GONCHARUK R, RAKHMONOV Z, STEGNII K, et al.Combined surgical treatment of giant cavernous hepatic hemangioma: a case report[J]. Int J Surg Case Rep, 2022, 94: 107012. [7] WU X, BAI X, YANG W, et al.Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound[J]. World J Gastroenterol, 2020, 26(9): 960-972. [8] GEYER T, CLEVERT D, SCHWARZ S, et al.Diagnostic value of CEUS prompting liver biopsy: histopathological correlation of hepatic lesions with ambiguous imaging characteristics[J]. Diagnostics (Basel), 2020, 11(1): 35. [9] FETZER D, KONO Y, RODGERS S.Using contrast-enhanced ultrasound to characterize focal liver lesions[J]. Clin Liver Dis (Hoboken), 2021, 17(3): 119-124. [10] YU G, RAMASAMY T, FAZZARI M, et al.Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion[J]. Nanotheranostics, 2022, 6(2): 215-229. [11] LI H, LI J.Application of real-time contrast-enhanced ultrasound in differential diagnosis of liver malignancies[J]. Can J Physiol Pharmacol, 2019, 97(5): 341-344. [12] ALSALEH M H, ALKHARS A S, ALBENSAAD M, et al.Incidental detection of synchronous benign hepatic and splenic hemangiomas on 18F-PSMA PET/CT[J]. Clin Nucl Med, 2024, 49(6): e298-e300. [13] HE F, ANTONUCCI L, YAMACHIKA S, et al.NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly[J]. J Hepatol, 2020, 72(6): 1182-1195. [14] YAN C, LI B, SUN X, et al.Laparoscopic hepatectomy is superior to open procedures for hepatic hemangioma[J]. Hepatobiliary Pancreat Dis Int, 2021, 20(2): 142-146. [15] LI H, DUAN X, WU Z, et al.Feasibility of laparoscopic enucleation for hemangioma in special hepatic segments[J]. Front Surg, 2023, 9: 1111307. [16] ERNST L, GRABHORN E, BRINKERT F, et al.Infantile hepatic hemangioma: avoiding unnecessary invasive procedures[J]. Pediatr Gastroenterol Hepatol Nutr, 2020, 23(1): 72-78. [17] DA ROCHA S M S, YAMANARI M G I, MATSUOKA M W, et al. Focal hyperechoic liver lesions in children: far beyond hemangiomas-pictorial essay[J]. Radiol Bras, 2020, 53(2): 122-128. [18] MATHEW R P, SAM M, RAUBENHEIMER M, et al.Hepatic hemangiomas: the various imaging avatars and its mimickers[J]. Radiol Med, 2020, 125(9): 801-815. [19] MÖLLER K, SAFAI ZADEH E, GÖRG C, et al. Focal liver lesions other than hepatocellular carcinoma in cirrhosis: diagnostic challenges[J]. J Transl Int Med, 2023, 10(4): 308-327. [20] MARUYAMA S, KODA M, MATONO T, et al.Association of tumor size and internal echo pattern with coagulopathy associated with hepatic hemangioma[J]. Mol Clin Oncol, 2021, 14(4): 83. [21] KLOTZ T, MONTORIOL P F, DA INES D, et al.Hepatic haemangioma: common and uncommon imaging features[J]. Diagn Interv Imaging, 2013, 94(9): 849-859. [22] KIM Y, LEE J, JUNG M.Atypical hepatic hemangioma with fluid-fluid level on CT and MRI: emphasis on added value of contrast-enhanced ultrasound findings[J]. J Belg Soc Radiol, 2022, 106(1): 56. [23] ZHAO Q X, HE X L, WANG K, et al.Deep learning model based on contrast-enhanced ultrasound for predicting early recurrence after thermal ablation of colorectal cancer liver metastasis[J]. Eur Radiol, 2023, 33(3): 1895-1905. |